New treatment options in bone metastases patients

Marek Pawlicki

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

9/2002
vol. 6

Send email

Copy url:

abstract:

New treatment options in bone metastases patients

Marek Pawlicki

Współcz Onkol (2002), vol. 6, 9, 608-615

Online publish date: 2003/03/26

View full text Get citation

Changes in the therapeutic strategies of bone metastases comprise novel surgical techniques, partially radiotherapy and new generations of biphosphonates. Surgical treatment is thought to be a basic therapy in certain patients with bone metastases. Biphosphonates have
been recently demonstrated to significantly improve survival of patients with some types of cancer e.g.
breast cancer and are supposed to be a crucial adjuvant treatment supplementing basic therapy (surgery, radiotherapy). Although radiotherapy has not been shown to improve survival of patients with bone metastases it significantly improves the quality of their life. Quite often it is
reasonable to support the sophisticated clinical therapies with some other kinds of treatment such as physical rehabilitation. Combination of different cancer treatment strategies may not only improve survival of patients (10-40%), but also
reduce the total costs of therapy mostly by decreasing the number of patients requiring long-term hospitalization.

keywords:

New treatment options in bone metastases patients

Marek Pawlicki

bone metastases, biphosphonates